(Image: DhruvStar Industry Insights | Original Artwork)
Launch of SIDDHI 2.0 and Key Releases
The Central Council for Research in Ayurvedic Sciences (CCRAS), Ministry of Ayush, launched SIDDHI 2.0 (Scientific Innovation in Drug Development, Healthcare & Integration) in Vijayawada. The two-day conclave was organised by the Regional Ayurveda Research Institute (RARI), Vijayawada, in collaboration with the Confederation of Indian Industry (CII), Vijayawada Zone.
CCRAS also released its medico-historical publication, Evolution of Ayurveda, Siddha & Unani Drug Regulations in India, along with the Drug Inventory Management System portal. The conclave serves as a national platform to enhance scientific, industrial and commercial collaboration in Ayurveda.
Read More: Antibiotic Nafithromycin to Target Drug-Resistant Respiratory Infections
Focus on Research-Led Ayurveda Innovation
Building on the momentum from PRAGATI-2024 (Pharma Research in Ayurgan and Techno-Innovation), SIDDHI 2.0 focuses on research-led product development, indigenous technology growth, faster translation of innovations, and stronger industry partnerships.
CCRAS highlighted Ayurveda’s growing role in managing lifestyle diseases and reaffirmed its commitment to collaborative research. The organisation outlined initiatives such as SPARK, SMART, PDF fellowships, and methodology programmes, and assured equitable IPR sharing for joint industry research.
Read More: BIRSA 101 Gene Therapy
Perspectives from Government, Industry and Research Institutions
The Government of Andhra Pradesh noted the need to expand Ayurveda education and manufacturing capacity in the state and proposed establishing a National Ayurveda Institute.
CCRAS shared that the organisation has validated over 150 Ayurvedic formulations, including herbo-mineral preparations, and encouraged the industry to use extensive CCRAS data on quality, safety, and toxicity. It also highlighted support for Ayurveda-based, AI-enabled and technology-driven start-ups.
Participants highlighted the need to modernise Ayurvedic formulations to enhance global competitiveness and called for stronger alignment among research, education, manufacturing, and industry development.
SIDDHI 2.0 as a National Translational Accelerator
Designed as a national accelerator for Ayurveda innovation, SIDDHI 2.0 aims to:
- Promote wider industry adoption of CCRAS technologies,
- Strengthen institutional linkages,
- Upgrade quality and regulatory frameworks, and
- Support globally competitive Ayurvedic pharmaceuticals.
By linking scientific research and development with industry collaboration, SIDDHI 2.0 supports the development of a modern, evidence-based and scalable Ayurveda ecosystem.
DhruvStar Industry Insights: What It Means for the Indian Alternative Medicine Industry
- Expanding Product Pipelines Through Research Collaboration: SIDDHI 2.0 opens avenues for companies to co-develop evidence-based Ayurvedic formulations using CCRAS data on safety, efficacy, and quality, reducing R&D costs and accelerating timelines.
- Opportunity for Technology-Enabled Ayurveda Solutions: With CCRAS supporting AI-driven and digital Ayurveda start-ups, firms can invest in diagnostic tools, personalised wellness solutions and digital therapeutics aligned with regulatory pathways.
- Industry Role in Workforce Development: As research activity grows, industry bodies can collaborate with academia on training, internships and translational research programmes to build a skilled talent pipeline for the Ayurveda ecosystem.
Sources
[1] PIB
Comments
Post a Comment